CNBC Finance
Amazon launches GLP-1 weight loss program, promising 'fast, convenient' access
Amazon is entering the weight loss drug market with a new GLP-1 program through Amazon Pharmacy, giving patients streamlined access to blockbuster medications like Novo Nordisk's Wegovy alongside emerging oral alternatives. The move signals Amazon's continued push to reshape how Americans access healthcare, leveraging its logistics muscle to compete in a booming obesity treatment space. With GLP-1 demand outpacing supply and affordability concerns mounting, Amazon's entry could meaningfully shift how patients navigate the market.
Read article →Yahoo Finance
Amazon investing up to $25 billion more in Anthropic
Amazon is deepening its bet on AI with a commitment of up to $25 billion in additional investment in Anthropic, the maker of the Claude AI model. The move signals Amazon's determination to compete with Microsoft and Google in the race to dominate enterprise AI infrastructure. With Anthropic's models deeply integrated into AWS, the partnership positions both companies as a formidable force in the rapidly consolidating AI market.
Read article →Yahoo Finance
Why Goldman Sachs thinks stocks will rip even higher
Goldman Sachs has raised its outlook on equities, citing resilient corporate earnings and a more favorable macroeconomic backdrop as fuel for further gains. The Wall Street giant's bullish call carries weight given its influence on institutional positioning. For investors already in the market, the message is clear: the rally may have more room to run.
Read article →Motley Fool
After Weeks of Extreme Fear, the Market Sentiment Index Just Jumped 20 Points. Here's What Comes Next.
Investor sentiment has staged a sharp reversal, with the Market Sentiment Index surging 20 points after an extended stretch of extreme fear gripping markets. Historically, such rapid swings in sentiment signal a potential inflection point — but whether this marks a genuine recovery or a brief reprieve remains the critical question. Traders and analysts will be watching closely for the underlying catalysts to determine if the momentum holds.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →